Clinical Trials Related to Bristol-Myers Squibb

Related studies linked through entity extraction aliases.

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

Status: COMPLETED
Phase: PHASE3

COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes

Status: COMPLETED
Phase: NA

A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)

Status: COMPLETED
Phase: PHASE2

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices

Status: COMPLETED
Phase: N/A

Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab

Status: COMPLETED
Phase: N/A

Early Patient Access Treatment Use Protocol CA204-220

Status: NO_LONGER_AVAILABLE
Phase: N/A

Yervoy Pregnancy Surveillance Study

Status: WITHDRAWN
Phase: N/A

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

Status: COMPLETED
Phase: N/A

Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant

Status: TERMINATED
Phase: PHASE1

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Treatment Patterns, Outcomes and Resource Use Study for Advanced Stage Non-Small Cell Lung Cancer (Squamous and Non-squamous) in the Kingdom of Saudi Arabia and United Arab Emirates

Status: COMPLETED
Phase: N/A

Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome

Status: TERMINATED
Phase: PHASE2

Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients

Status: COMPLETED
Phase: PHASE2

Sub-Clinical Atrial Fibrillation Biomarker Study

Status: COMPLETED
Phase: N/A

Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia

Status: COMPLETED
Phase: N/A

Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer

Status: COMPLETED
Phase: PHASE1

ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

Status: COMPLETED
Phase: N/A

A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer

Status: COMPLETED
Phase: NA

The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects

Status: COMPLETED
Phase: PHASE1

An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread

Status: COMPLETED
Phase: PHASE2